No Data
No Data
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and
Relay Therapeutics Upgraded by Barclays Ahead of Data Readout
Express News | Barclays Upgrades Relay Therapeutics to Overweight, Maintains Price Target to $15
Express News | Relay Therapeutics Inc : Barclays Raises to Overweight From Equal Weight
Optimistic Buy Rating for Relay Therapeutics: Pipeline Progress and Financial Stability Drive Analyst Confidence
Relay Therapeutics Price Target Maintained With a $24.00/Share by JMP Securities
Relay Therapeutics Price Target Maintained With a $24.00/Share by JMP Securities